ST. LOUIS -- EMS provider
LaBarge reported December quarter net sales rose 2% year-over-year to $68.2 million. Net earnings declined to $249,000, from $3.4 million last year, on a writedown of inventory and debts from a large customer.
The company struck a ominous tone in a press release issued today. “Despite relative strength in defense, our largest market sector, we
anticipate that fiscal 2009 second-half results will be negatively
impacted by the declines in current-year industrial and natural
resources orders, and the absence of Eclipse shipments which amounted to
approximately $8 million in last year’s second half," chief executive and president Craig LaBarge said.
"Specifically, we
expect that fiscal 2009 shipments to industrial and natural resources
customers will weaken further in the fiscal 2009 second half. Based on
the visibility we have today, we expect that fiscal 2009 second-half
sales, excluding revenues from the Pensar acquisition, will be down a
little more than 20% from last year’s second half. Including
revenue from the Pensar acquisition, we expect fiscal 2009 second-half
sales will be down approximately 5% from last year’s second-half
levels."
During the quarter, LaBarge took a one-time writeoff of $3.7 million for inventory and accounts
receivable related to the Chapter 11 bankruptcy reorganization of Eclipse Aviation.
The newly acquired Pensar Electronic Solutions operation, which LaBarge purchased on Dec. 22, accounted for less than $200,000 in sales during the quarter. The site generated $52.4 million in
calendar 2008 sales, and adds
several new customers and expands LaBarge’s presence in the
medical and industrial markets, the company said.
Gross margin was 15%, down from 19.9% in the year-ago second quarter. Excluding the Eclipse-related
charge, gross margin was
21.2%. Net cash flow from operations was $6 million, up from 97,000.
Shipments to defense customers mad up 49% of net sales, up from 35%
last year. Natural resources customers made up 20% of net sales,
industrial customers 18%, and medical 6%.